Sort
82,697 grants matching “vaccine development”
A Cytomegalovirus-based Vaccine Targeting the Pre-erythrocytic Stage of Malaria
$812,475Klaus J Frueh · Oregon Health & Science University · R01 · FY2017 · AI
Administrative Core
$812,399Cliburn C Chan · Duke University · U54 · FY2025 · AI
Immune response, transmission model, and contact network determinants of disease spread
$812,397Bruce Rogers · Duke University · U54 · FY2025 · AI
Inferring the rules of antibody evolution using replicated germinal centers
$812,354Gabriel D Victora · Rockefeller University · R01 · FY2025 · AI
Inferring the rules of antibody evolution using replicated germinal centers
$812,354Gabriel D Victora · Rockefeller University · R01 · FY2024 · AI
Immunological characterization of the P. vivax DBP
$812,322John Adams · University Of South Florida · R01 · FY2015 · AI
Engineering Protein Antigens and their Presentation from Multivalent Scaffolds
$812,281Ravi S Kane · Georgia Institute Of Technology · R01 · FY2025 · AI
Core B: GMP Cell and RNA Manufacturing
$812,276Bruce L. Levine · University Of Pennsylvania · P01 · FY2019 · CA
Development of mRNA-platform vaccines
$812,208Fredrick Heath Damron · West Virginia University · R01 · FY2024 · AI
Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120
$812,190Asim K Debnath · New York Blood Center · R01 · FY2018 · AI
AAV-mediated delivery of eCD4-Ig for prevention and treatment of perinatal HIV infection
$812,183Mauricio De Aguiar Martins · University Of Florida · R01 · FY2024 · HD
Impact of the Intestinal Microbiome on HIV/SIV Vaccines
$812,077Herbert W Virgin · Washington University · R01 · FY2017 · OD
SARS-CoV-2 correlates of protection in a Latino-origin population
$812,000Carlos A Sariol · University Of Puerto Rico Med Sciences · U01 · FY2024 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$811,997Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Developing Classroom-based Undergraduate Research Experiences in Antibody Bioengineering
$811,953Sandra G Porter · Digital World Biology · · FY2021 · EDU
Structure-function studies of the membrane-interacting domains of HIV-1 Env spike
$811,866Bing Chen · Boston Children'S Hospital · R01 · FY2019 · AI
Second-generation Gene Transfer Vector-based Anti-cocaine Vaccines
$811,852Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2013 · DA
Development of Long-acting Cocaine Hydrolase as a Treatment for Cocaine Abuse
$811,835Chang-Guo Zhan · University Of Kentucky · UH3 · FY2019 · DA
Immuno-Genetic Epidemiology of Complex Malaria in India
$811,765Jane Carlton · New York University · U19 · FY2014 · AI
Epigenetic Therapy for Thoracic Malignancies
$811,718David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination
$811,693Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapy
$811,645Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2022 · AI
Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II
$811,565Peter M. Pushko · Medigen, Inc. · R44 · FY2016 · AI
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis
$811,554Shabaana A. Khader · Washington University · R01 · FY2021 · AI
Forward Genetic Analysis of Innate Immune Signaling
$811,539Bruce A Beutler · Scripps Research Institute, The · U19 · FY2014 · AI